Back
Alimera Sciences Vs. Kymera Therapeutics Industry Stock Comparison
Sell
47
ALIM
Alimera Sciences
Last Price:
5.54
Seasonality Move:
-13.1%
Buy
62
KYMR
Kymera Therapeutics
Last Price:
44.79
Seasonality Move:
25.63%
Sell
47
Alimera Sciences (ALIM)
is a Sell
Is Alimera Sciences a Buy, Sell or Hold?
- The current Alimera Sciences [ALIM] share price is $5.19. The Score for ALIM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- ALIM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.88. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALIM Stock Price Chart
What is Alimera Sciences's stock price today?
-
The Alimera Sciences share price today is $5.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALIM is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.88
The current trend is moderately bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALIM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 21.49 | Sell |
Chaikin Money Flow: | 6881477 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.47 - 5.63) | Sell |
Bollinger Bands (100): | (3.38 - 5.68) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.1 | Buy |
Relative Strength Index (14 RSI): | 55.23 | Buy |
Chaikin Money Flow: | 209294 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.77 - 48.09) | Buy |
Bollinger Bands (100): | (32.74 - 44.46) | Buy |
ALIM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.5 | Sell |
20-day SMA: | 5.55 | Sell |
50-day SMA: | 5.56 | Sell |
200-day SMA: | 4.15 | Buy |
8-day EMA: | 5.47 | Sell |
20-day EMA: | 5.52 | Sell |
50-day EMA: | 5.3 | Sell |
200-day EMA: | 4.34 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.77 | Buy |
20-day SMA: | 46.4 | Buy |
50-day SMA: | 42.99 | Buy |
200-day SMA: | 35.58 | Buy |
8-day EMA: | 46.64 | Buy |
20-day EMA: | 46.04 | Buy |
50-day EMA: | 43.26 | Buy |
200-day EMA: | 36.12 | Buy |
Alimera Sciences Earnings Growth & ALIM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.04 per share, an increase this year of $0.24 per share, and an increase next year of $0.24 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.51 per share.
Alimera Sciences Technical Analysis
Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |